Related Experiment Video
Updated: Oct 2, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiac complications in a geriatric population hospitalized with COVID-19: The OCTA-COVID cohort
Ramos-Sánchez Mónica1, Quezada-Feijoó Maribel1, Jaramillo Javier2
1Cardiology Department, Hospital Central de la Cruz Roja, Madrid, Spain; Facultad de Medicina, Universidad Alfonso X el Sabio, Madrid, Spain.
Insights
Elderly patients hospitalized with COVID-19 frequently experience cardiac complications, particularly congestive heart failure and new-onset atrial fibrillation, leading to longer hospital stays.
Area of Science:
- Geriatric Medicine
- Cardiology
- Infectious Diseases
Background:
- The geriatric population is highly susceptible to severe outcomes from coronavirus disease (COVID-19).
- Cardiovascular complications are a significant concern in elderly patients with COVID-19.
Purpose of the Study:
- To investigate the incidence of cardiological complications in elderly individuals hospitalized with COVID-19.
- To analyze the association between cardiac complications and hospital stay duration.
Main Methods:
- A prospective observational study included 305 patients aged 75 years and older diagnosed with COVID-19.
- Data collected included epidemiological, geriatric, clinical, and laboratory variables.
- Cardiovascular events and mortality were documented during hospitalization and at a 12-month follow-up.
Main Results:
- Nearly 30% of patients (89/305) experienced cardiac complications during hospitalization, with acute heart failure (15.1%) and new-onset atrial fibrillation (6.5%) being most common.
- Patients with cardiac complications had significantly longer hospital stays (p<0.001).
- During 12-month follow-up, 20.8% experienced cardiovascular events, predominantly congestive heart failure (16.7%).
Conclusions:
- Cardiovascular complications are common in geriatric patients with COVID-19 and are linked to prolonged hospitalization.
- Congestive heart failure and atrial fibrillation were the most frequent cardiac events observed.
Purpose:
The geriatric population is especially vulnerable to coronavirus disease (COVID-19) and its potential complications. We sought to analyze the incidence of cardiological complications in an elderly population hospitalized for COVID-19.
Methods:
A prospective observational longitudinal that included patients ≥75 years of age with diagnosis of COVID-19 admitted to the Geriatric Department from March to May 2020. Epidemiological, geriatric, clinical and laboratory test variables were collected. Cardiovascular events, including de novo atrial fibrillation (AF), acute coronary syndrome (ACS), congestive heart failure (CHF), pulmonary embolism and in-hospital death, were documented. A follow-up was carried out at 12 months through a telephone interview as well as using electronic medical records, collecting cardiac events and mortality.
Results:
305 patients were included; 190 (62.3%) were female, with median age of 87 years (interquartile range (82-91)). More than half of the patients had a history of cardiac disease, with AF being the most common and affecting 85 (27.9%) patients. During hospitalization, 112 (36.7%) patients died. Eighty-nine (29.2%) patients presented cardiac complications. Acute heart failure was the most prevalent (46; 15.1%), followed by new-onset AF (20; 6.5%), pulmonary embolism (17; 5.6%), and ACS (5; 1.6%). Patients with cardiac complications had a longer hospital stay (p<0.001). During follow-up, 29 (15.1%) died, and 40 (20.8%) patients had a cardiovascular event being CHF the most prevalent complication (16.7%).
Conclusion:
The incidence of cardiovascular complications in geriatric patients is high and is associated with a longer hospital stay. CHF was the most frequent event, followed by AF.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Introduction Cardiac Emergencies
Pneumonia III: Complications and Assessment
Coronary Artery Disease III: Clinical Manifestations
Heart Failure II: Pathophysiology
Cardiomyopathy VI: Nursing Management

